Managing Pulmonary Hypertension in Times of COVID-19
- PMID: 32675934
- PMCID: PMC7355117
- DOI: 10.6515/ACS.202007_36(4).20200619C
Managing Pulmonary Hypertension in Times of COVID-19
References
-
- The epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVID-19). Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41:145–151. - PubMed
-
- Huang WC, Hsu CH, Sung SH, et al. 2018 TSOC guideline focused update on diagnosis and treatment of pulmonary arterial hypertension. J Formos Med Assoc. 2019;118:1584–1609. - PubMed
-
- Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of The European Society of Cardiology (ESC) and The European Respiratory Society (ERS): endorsed by:Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119. - PubMed
-
- Klinger JR, Elliott CG, Levine DJ, et al. Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest. 2019;155:565–586. - PubMed